Abstract:PURPOSE To compare the therapeutic outcomes of single-session gamma knife surgery (GKS) and 2-stage GKS for large (diameter ≥ 2 cm) brain metastases from lung cancer. METHODS For the first time, patients with brain metastases from a single primary tumor were selected, and the treatment data of patients with large lung brain metastases from lung adenocarcinoma treated with single-session or 2-stage GKS between January 2019 and June 2022 at our hospital were retrospectively analyzed. Seventy-seven patients (85 lesions) were in the single-session GKS group, while 62 patients (72 lesions) were in the 2-stage GKS group. Propensity score matching of cases was performed because of differences in the number of patients and clinical factors prior to GKS between the two groups. Finally, 90 patients (45 in each group) were included in the matched case-control study. Therapeutic outcomes were measured based on the Karnofsky performance status score, local tumor control, cumulative incidence of radiation necrosis, and overall survival of each patient. RESULTS In the overall patient cohort, the cumulative incidence of radiation necrosis was significantly lower in the staged GKS group than in the single-session GKS group (5.0% vs. 18.4% at 1 year, p = 0.028). In the case-matched cohort, the cumulative incidence of neurological death was significantly lower in the staged GKS group than in the single-session GKS group (2.4% vs. 4.9% at 1 year, p = 0.045). In both the overall and case-matched cohorts, the rate of tumor volume change after GKS was significantly higher in the staged GKS group (67.5%, 67.5%) than in the single-session GKS group (53.0, 51.1%) (p < 0.05). The local tumor control and rate of tumor volume change were also significantly better in the staged GKS group than in the single-session GKS group. No significant difference in overall survival was observed between the two groups. Besides, the rate of tumor volume change is a significant factor that influences the long-term efficacy of local tumor control. Additionally, the control of the primary tumor is an independent influencing factor for the overall survival of patients. CONCLUSION Our findings suggest that staged GKS is safer and more efficacious than single-session GKS for large brain metastases (≥ 2 cm in diameter) from lung adenocarcinoma, and that the rate of tumor volume change after treatment influences local tumor progression.

Outcomes of 2-SSRS plus bevacizumab therapy strategy for brainstem metastases (BSM) over 2 cm3: a multi-center study

Efficacy and safety of a "sandwich therapy" based on staged stereotactic radiosurgery and bevacizumab for large brainstem metastases

Comparison of Treatment Outcomes of Single-Session and 2-Stage Gamma Knife Surgery for Large Brain Metastases from Lung Adenocarcinoma

Stereotactic Radiosurgery with Whole Brain Radiotherapy Combined with Bevacizumab in the Treatment of Brain Metastases from NSCLC.

Prognostic Analysis of Stereotactic Radiosurgery for Brain Metastases: a Single-Center Retrospective Study

‘Sandwich Treatment’ for Posterior Fossa Brain Metastases with Volume Larger Than 4cm 3 : a Multicentric Retrospective Study

Metastatic Neoplasm Volume Kinetics Following 2-Stage Stereotactic Radiosurgery

Whole Brain Radiotherapy-Based Combined Modality Treatment of Brain Metastases from Non-Small Cell Lung Cancer: A Retrospective Analysis of Prognostic Factors

Rbio-04. Outcomes Of Radiosurgery For Who Grade 2 Meningiomas: The Role Of Ki-67 Index In Guiding The Tumor Margin Dose

Bevacizumab As a Treatment for Radiation Necrosis Following Stereotactic Radiosurgery for Brain Metastases: Clinical and Radiation Dosimetric Impacts.

Glioblastoma multiforme in the brainstem in a young adult.

Single-Fraction Stereotactic Radiosurgery (SRS) Alone Versus Surgical Resection and SRS for Large Brain Metastases: A Multi-institutional Analysis

The Predictors of Clinical Outcomes in Brainstem Arteriovenous Malformations after Stereotactic Radiosurgery

Postoperative Stereotactic Radiosurgery (Srs) Without Whole-Brain Radiation Therapy (Wbrt) For Brain Metastases: Potential Role Of Tumor Size

Stereotactic radiosurgery and radiotherapy for brainstem metastases: An international multicenter analysis

Comparing with treatment outcome of brain metastases from lung adenocarcinoma with EGFR wild-type or drug resistance for stereotactic radiotherapy combined with bevacizumab±brain radiotherapy

Bevacizumab reduces cerebral radiation necrosis due to stereotactic radiotherapy in non-small cell lung cancer patients with brain metastases: an inverse probability of treatment weighting analysis

Multi-institutional study of ‘Sandwich treatment’ for motor area large brain metastases (LBM) with diameter over 3 cm

Surgical Resection Followed by Stereotactic Radiosurgery (S+SRS) Versus SRS Alone for Large Posterior Fossa Brain Metastases: A Comparative Analysis of Outcomes and Factors Guiding Treatment Modality Selection

Stereotactic Radiation Therapy (SRT) for Brain Metastases of Multiple Primary Tumors: A Single Institution Retrospective Analysis.

A New Strategy of CyberKnife Treatment System Based Radiosurgery Followed by Early Use of Adjuvant Bevacizumab Treatment for Brain Metastasis with Extensive Cerebral Edema